95 related articles for article (PubMed ID: 23803187)
41. Exosomal CXCL14 Contributes to M2 Macrophage Polarization through NF-
Tian HY; Liang Q; Shi Z; Zhao H
Oxid Med Cell Longev; 2022; 2022():7616696. PubMed ID: 35669852
[TBL] [Abstract][Full Text] [Related]
42. Expression of a chemokine BRAK/CXCL14 in oral floor carcinoma cells reduces the settlement rate of the cells and suppresses their proliferation in vivo.
Ito S; Ozawa S; Ikoma T; Yajima N; Kiyono T; Hata R
Biomed Res; 2010 Jun; 31(3):199-206. PubMed ID: 20622470
[TBL] [Abstract][Full Text] [Related]
43. A complex pattern of chemokine receptor expression is seen in osteosarcoma.
von Luettichau I; Segerer S; Wechselberger A; Notohamiprodjo M; Nathrath M; Kremer M; Henger A; Djafarzadeh R; Burdach S; Huss R; Nelson PJ
BMC Cancer; 2008 Jan; 8():23. PubMed ID: 18215331
[TBL] [Abstract][Full Text] [Related]
44. The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.
AbdelMageed M; Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752131
[TBL] [Abstract][Full Text] [Related]
45. Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26 S proteasome.
Peterson FC; Thorpe JA; Harder AG; Volkman BF; Schwarze SR
J Mol Biol; 2006 Nov; 363(4):813-22. PubMed ID: 16987528
[TBL] [Abstract][Full Text] [Related]
46. High expression of CXCL14 is a biomarker of lung adenocarcinoma with micropapillary pattern.
Sata Y; Nakajima T; Fukuyo M; Matsusaka K; Hata A; Morimoto J; Rahmutulla B; Ito Y; Suzuki H; Yoshino I; Kaneda A
Cancer Sci; 2020 Jul; 111(7):2588-2597. PubMed ID: 32403160
[TBL] [Abstract][Full Text] [Related]
47. C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression.
Yang XY; Ozawa S; Kato Y; Maehata Y; Izukuri K; Ikoma T; Kanamori K; Akasaka T; Suzuki K; Iwabuchi H; Kurata SI; Katoh I; Sakurai T; Kiyono T; Hata RI
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31014014
[TBL] [Abstract][Full Text] [Related]
48. The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses.
Westrich JA; Vermeer DW; Colbert PL; Spanos WC; Pyeon D
Mol Carcinog; 2020 Jul; 59(7):794-806. PubMed ID: 32212206
[TBL] [Abstract][Full Text] [Related]
49. CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test.
Lee E; Ahn S; Jin SH; Lee M; Pyo JJ; Shin JC; An S; Ha J; Noh M
Toxicol Appl Pharmacol; 2020 Jan; 386():114828. PubMed ID: 31734321
[TBL] [Abstract][Full Text] [Related]
50. Chemokine CXCL14; a double-edged sword in cancer development.
Gowhari Shabgah A; Haleem Al-Qaim Z; Markov A; Valerievich Yumashev A; Ezzatifar F; Ahmadi M; Mohammad Gheibihayat S; Gholizadeh Navashenaq J
Int Immunopharmacol; 2021 Aug; 97():107681. PubMed ID: 33932697
[TBL] [Abstract][Full Text] [Related]
51. The negative feedback loop FAM129A/CXCL14 aggravates the progression of esophageal cancer.
Cao JW; Cui WF; Zhu HJ
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4220-4227. PubMed ID: 35776020
[TBL] [Abstract][Full Text] [Related]
52. An N-terminally truncated mutant of human chemokine CXCL14 has biological activity.
Neira JL; Sandí MJ; Bacarizo J; Archange C; Camara-Artigas A; Iovanna JL
Protein Pept Lett; 2013 Aug; 20(8):955-67. PubMed ID: 23270429
[TBL] [Abstract][Full Text] [Related]
53. Elevated expression of CXC chemokines in pediatric osteosarcoma patients.
Li Y; Flores R; Yu A; Okcu MF; Murray J; Chintagumpala M; Hicks J; Lau CC; Man TK
Cancer; 2011 Jan; 117(1):207-17. PubMed ID: 20806347
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of CXCL14 disrupts neurovascular patterning during ocular development.
Ojeda AF; Munjaal RP; Lwigale PY
Dev Biol; 2017 Mar; 423(1):77-91. PubMed ID: 28095300
[TBL] [Abstract][Full Text] [Related]
55. The chemokine CXCL14 is negatively associated with obesity and concomitant type-2 diabetes in humans.
Cereijo R; Quesada-López T; Gavaldà-Navarro A; Tarascó J; Pellitero S; Reyes M; Puig-Domingo M; Giralt M; Sánchez-Infantes D; Villarroya F
Int J Obes (Lond); 2021 Mar; 45(3):706-710. PubMed ID: 33414488
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive analysis of CXCL14 uncovers its role during liver metastasis in colon cancer.
Zhou L; Zhang Y; Wei M; Du K; Lin J; Wei L
BMC Gastroenterol; 2023 Aug; 23(1):273. PubMed ID: 37563546
[TBL] [Abstract][Full Text] [Related]
57. The relationship between metastatic potential and in vitro mechanical properties of osteosarcoma cells.
Holenstein CN; Horvath A; Schär B; Schoenenberger AD; Bollhalder M; Goedecke N; Bartalena G; Otto O; Herbig M; Guck J; Müller DA; Snedeker JG; Silvan U
Mol Biol Cell; 2019 Mar; 30(7):887-898. PubMed ID: 30785850
[TBL] [Abstract][Full Text] [Related]
58. The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy.
Giacobbi NS; Mullapudi S; Nabors H; Pyeon D
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400076
[TBL] [Abstract][Full Text] [Related]
59. LDHB may be a significant predictor of poor prognosis in osteosarcoma.
Li C; Chen Y; Bai P; Wang J; Liu Z; Wang T; Cai Q
Am J Transl Res; 2016; 8(11):4831-4843. PubMed ID: 27904684
[TBL] [Abstract][Full Text] [Related]
60. The epigenetic regulation of CXCL14 plays a role in the pathobiology of oral cancers.
Nakayama R; Arikawa K; Bhawal UK
J Cancer; 2017; 8(15):3014-3027. PubMed ID: 28928893
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
